Literature DB >> 29359238

Prognostic factors of ALK-negative anaplastic large-cell lymphoma: a single-institution experience.

Raoudha Doghri1, Linda Bel HadjKacem1, Yoldez Houcine2, Lamia Charfi1, Maha Driss1, Karima Kacem3, Nadia Boujelbene1, Karima Mrad1.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29359238      PMCID: PMC5835212          DOI: 10.1007/s00277-018-3239-3

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  4 in total

Review 1.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

2.  ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.

Authors:  Kerry J Savage; Nancy Lee Harris; Julie M Vose; Fred Ullrich; Elaine S Jaffe; Joseph M Connors; Lisa Rimsza; Stefano A Pileri; Mukesh Chhanabhai; Randy D Gascoyne; James O Armitage; Dennis D Weisenburger
Journal:  Blood       Date:  2008-04-02       Impact factor: 22.113

3.  Clinical and prognostic differences between ALK-negative anaplastic large cell lymphoma and peripheral T cell lymphoma, not otherwise specified: a single institution experience.

Authors:  Xiu-Wen Deng; Xi-Mei Zhang; Wei-Hu Wang; Shu-Lian Wang; Jing Jin; Hui Fang; Hua Ren; Yue-Ping Liu; Xiao-Hui He; Mei Dong; Yong-Wen Song; Ye-Xiong Li
Journal:  Ann Hematol       Date:  2016-05-21       Impact factor: 3.673

4.  ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified.

Authors:  R L ten Berge; P C de Bruin; J J Oudejans; G J Ossenkoppele; P van der Valk; C J L M Meijer
Journal:  Histopathology       Date:  2003-11       Impact factor: 5.087

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.